| Issue Date | Title | Author(s) |
| 2020-11-03 | MLC tracking for lung SABR is feasible, efficient and delivers high-precision target dose and lower normal tissue dose. | Booth, J; Caillet, V; Briggs, A; Hardcastle, N; Angelis, G; Jayamanne, D; Shepherd, M; Podreka, A; Szymura, K; Nguyen, DT; Poulsen, P; O'Brien, R; Harris, B; Haddad, C; Eade, T; Keall, P |
| 2020-10-31 | Diagnostic value of serum HER2 levels in breast cancer: a systematic review and meta-analysis. | Shamshirian, A; Aref, AR; Yip, GW; Ebrahimi Warkiani, M; Heydari, K; Razavi Bazaz, S; Hamzehgardeshi, Z; Shamshirian, D; Moosazadeh, M; Alizadeh-Navaei, R |
| 2020-10 | Is multileaf collimator tracking or gating a better intrafraction motion adaptation strategy? An analysis of the TROG 15.01 stereotactic prostate ablative radiotherapy with KIM (SPARK) trial. | Hewson, EA; Nguyen, DT; O'Brien, R; Poulsen, PR; Booth, JT; Greer, P; Eade, T; Kneebone, A; Hruby, G; Moodie, T; Hayden, AJ; Turner, SL; Hardcastle, N; Siva, S; Tai, KH; Martin, J; Keall, PJ |
| 2020-10 | Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects against MYCN-amplified neuroblastoma. | Tee, AE; Ciampa, OC; Wong, M; Fletcher, JI; Kamili, A; Chen, J; Ho, N; Sun, Y; Carter, DR; Cheung, BB; Marshall, GM; Liu, PY; Liu, T |
| 2019-09-04 | Heterozygous loss of keratinocyte TRIM16 expression increases melanocytic cell lesions and lymph node metastasis | Sutton, SK; Cheung, BB; Massudi, H; Tan, O; Koach, J; Mayoh, C; Carter, DR; Marshall, GM |
| 2019-07-01 | Dosimetric impact of intrafraction rotations in stereotactic prostate radiotherapy: A subset analysis of the TROG 15.01 SPARK trial | Wolf, J; Nicholls, J; Hunter, P; Nguyen, DT; Keall, P; Martin, J |
| 2018-06-15 | Network modeling of microRNA-mRNA interactions in neuroblastoma tumorigenesis identifies miR-204 as a direct inhibitor of MYCN | Ooi, CY; Carter, DR; Liu, B; Mayoh, C; Beckers, A; Lalwani, A; Nagy, Z; De Brouwer, S; Decaesteker, B; Hung, TT; Norris, MD; Haber, M; Liu, T; De Preter, K; Speleman, F; Cheung, BB; Marshall, GM |
| 2018-12-10 | Lymphocyte-Specific Chromatin Accessibility Pre-determines Glucocorticoid Resistance in Acute Lymphoblastic Leukemia | Jing, D; Huang, Y; Liu, X; Sia, KCS; Zhang, JC; Tai, X; Wang, M; Toscan, CE; McCalmont, H; Evans, K; Mayoh, C; Poulos, RC; Span, M; Mi, J; Zhang, C; Wong, JWH; Beck, D; Pimanda, JE; Lock, RB |
| 2011-04-01 | Use of cyclin D1 in conjunction with human papillomavirus status to predict outcome in oropharyngeal cancer | Hong, AM; Dobbins, TA; Lee, CS; Jones, D; Fei, J; Clark, JR; Armstrong, BK; Harnett, GB; Milross, CG; Tran, N; Peculis, LD; Ng, C; Milne, AG; Loo, C; Hughes, LJ; Forstner, DF; O'Brien, CJ; Rose, BR |
| 2017-05-16 | PD-L1 expressing circulating tumour cells in head and neck cancers | Kulasinghe, A; Perry, C; Kenny, L; Warkiani, ME; Nelson, C; Punyadeera, C |
